These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29170084)

  • 21. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
    Jin Y; Guan S; Liu L; Sun S; Lee KH; Wei J
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e37-41. PubMed ID: 24811068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
    Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Chen H; Sun G; Han Z; Wang H; Li J; Ye H; Song C; Zhang J; Wang P
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295640
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
    Chang C; Wang MJ; Bi XF; Fan ZY; Feng D; Cai HQ; Zhang Y; Xu X; Cai Y; Qi J; Wei WQ; Hao JJ; Wang MR
    J Clin Lab Anal; 2021 Sep; 35(9):e23904. PubMed ID: 34288108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
    Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
    EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.
    Liu WL; Zhang G; Wang JY; Cao JY; Guo XZ; Xu LH; Li MZ; Song LB; Huang WL; Zeng MS
    Biochem Biophys Res Commun; 2008 Oct; 375(3):440-5. PubMed ID: 18722351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
    Li J; Li M; Gao F; Ge X
    Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
    Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
    PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
    Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B
    Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
    BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma.
    Li L; Liu M; Lin JB; Hong XB; Chen WX; Guo H; Xu LY; Xu YW; Li EM; Peng YH
    Dis Markers; 2017; 2017():2534648. PubMed ID: 28298808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma.
    Zheng Q; Zhang L; Tu M; Yin X; Cai L; Zhang S; Yu L; Pan X; Huang Y
    Clin Chim Acta; 2021 Sep; 520():126-132. PubMed ID: 34119530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
    Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma.
    Cheng Y; Xu J; Guo J; Jin Y; Wang X; Zhang Q; Liu L
    Clin Transl Oncol; 2013 May; 15(5):398-402. PubMed ID: 23054755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma.
    Yie SM; Ye SR; Ma XL; Xie K; Zhang JB; Cao M; He X; Hu ZB; Yang CL; Zhang J; Zeng J
    Br J Cancer; 2016 Dec; 115(12):1555-1564. PubMed ID: 27875523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.